CN101670070A - Traditional Chinese medicine composition for treating hypertension - Google Patents
Traditional Chinese medicine composition for treating hypertension Download PDFInfo
- Publication number
- CN101670070A CN101670070A CN200910075332A CN200910075332A CN101670070A CN 101670070 A CN101670070 A CN 101670070A CN 200910075332 A CN200910075332 A CN 200910075332A CN 200910075332 A CN200910075332 A CN 200910075332A CN 101670070 A CN101670070 A CN 101670070A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- fructus
- cortex
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine for treating hypertension, which is prepared by the following raw materials by weight ratio: 10-30 of codonopsis, 20-60 of membranous milkvetch root, 20-60 of dried rehmannia root, 20-60 of figwort root, 15-40 of dwarf lilyturf tuber, 15-30 of common anemarrhena rhizome, 15-40 of white paeony root, 10-30 of Chinese angelica, 20-50 of common yam rhizome, 10-30 of baical skullcap root, 10-30 of cortex phellodendri, 10-30 of gardenia, 10-30 of lightyellow sophora root, 20-60 of cassia seed, 20-60 of ruddle, 10-50 of mirabilite, 10-20 of rhubarb, 15-50 of salvia miltiorrhiza, 10-30 of cortex moutan, 10-20 of common burreed rhizome, 10-20 of rhizoma zedoariae, 10-40 of swordlike atractylodes rhizome, 20-40 of largehead atractylodes rhizome,20-50 of Indian buead, 15-40 of oriental waterplantain rhizome, 15-40 of snakegourd fruit, 10-30 of pinellia tuber, 15-40 of malaytea scurfpea fruit, 15-60 of common macrocarpium fruit, 10-20 of medcinal evodia fruit, 5-20 of cassia bark, 20-60 of barbary wolfberry fruit and 15-40 of desertliving cistanche. The traditional Chinese medicine improves the systemic symptoms by adjusting yin, yang, qiand blood of a human body, thereby achieving the effect of reducing the blood pressure and the significant efficacy; and the traditional Chinese medicine also has good efficacy for other related diseases caused by the hypertension and can prevent relevant complications of cerebral hemorrhage, stroke, coronary heart disease, high blood lipids, arteriosclerosis and the like, and improve the qualityof life of a patient.
Description
One, technical field
The present invention relates to the hypertensive medicine of a kind of treatment, relate in particular to the hypertensive Chinese medicine of a kind of treatment.
Two, background technology
Hypertension is a kind of commonly encountered diseases, and clinical manifestation is easy on the trigger, and neurasthenia's phenomenon is arranged, dizzy headache has dizzy state, and the phenomenon of tinnitus is often arranged, bipod shakiness when walking, as as speeding across the sky, top-heavy, head feels that weight is arranged, the action rapid breathing, abdominal part has the sense of expansion, and press just like pillow in the chest, and trick is ice-cold.The traditional Chinese medical science thinks that hypertension is to belong to congestion, and congestion is stagnated and loose, and is deficiency of the liver and kindey, and liver-yang is high partially, intimately due to the liver-wind pathogen upward attacking orifices in head.Hypertensive reason has five: (one) deficiency of both vital energy and Yin; (2) the hot polymerization fire is contained: (three) weight in wet base expectorant is turbid: (four) stasis becomes the stasis of blood; (5) unit is deficient down.Current, treatment hypertension Western medicine commonly used, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, and utilization Chinese herbal treatment or auxiliary treatment hypertension are the work of always studying, but present medicine can not effect a radical cure, and curative effect can not be satisfactory.
Three, summary of the invention
Purpose of the present invention addresses the above problem exactly, provides a kind of treatment hypertensive Chinese medicine, and it can treat and effect a radical cure hypertension, and the relevant disease that other hypertension causes is also had good curative effect.
Technical solution of the present invention be according to the traditional Chinese medical science to hypertensive rule, i.e. QI invigorating YIN nourishing, heat clearing away reducing internal heat, damp eliminating expectorant, blood circulation promoting and blood stasis dispelling and the supporing yang method of reinforcing, the present invention forms according to above-mentioned rule, pharmacological action is as follows:
1, QI invigorating YIN nourishing: QI invigorating, qi as the commander of blood, the traditional Chinese medical science is at first paid attention to gas, and the deficiency of vital energy then blood loses motive force.No matter in the body and body surface, QI-insufficiency is immunity degradation then, and hundred heresies can be invaded.The Radix Codonopsis and the Radix Astragali are the medicine of QI invigorating among the present invention.YIN nourishing, gas are sun, and blood is cloudy, and YIN and YANG promoting each other can be maintained total balance of the body, otherwise negative and positive are determined from then life disappearance.The Radix Rehmanniae, Radix Scrophulariae, Radix Ophiopogonis, the Rhizoma Anemarrhenae, the Radix Paeoniae Alba, Radix Angelicae Sinensis and Rhizoma Dioscoreae are the medicine of QI invigorating YIN nourishing among the present invention.
2, heat clearing away reducing internal heat: heat clearing away: one of hypertensive paathogenic factor is exactly that the hot polymerization fire is contained.Interior heat localization is not loose, and one fry in shallow oil the cloudy liquid of consumption; The two can make Tianjin blood retrogradation, the disease of causing many apoplexy.Heat clearing away person is to want with YIN nourishing, and the medicine heat clearing away of the auxiliary YIN nourishing of Radix Scutellariae, Cortex Phellodendri and Fructus Gardeniae strengthens clinical efficacy.Reducing internal heat: fire is the fire-toxin of inside of human body, if long-term existence is inevitable very dangerous in body.Removing fire-toxin rubbish, is the method for taking stopgap measures, and also is the plan of emergency.Natrii Sulfas, Radix Et Rhizoma Rhei, Haematitum, Semen Cassiae all are the medicine of the fire-toxin of dispelling.
3, damp eliminating expectorant: damp eliminating: middle medical book is said: " damp viscous ", sticking person, silk fabric is also; Stagnant person hesitates to move forward, and the meaning of stop also; Its wet at first duty in spleen." the taste dependent territory is reported lunar property to middle medical book meaning, and damp-stagnancy is then given birth to cold for a long time." clinical need arrange it with the medicine of warming the spleen dampness and eliminating dampness by diuresis, dampness removing.The present invention comes warming the spleen dampness and eliminating dampness by diuresis, dampness removing with Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Poria and Rhizoma Alismatis.Expectorant: middle medical book meaning " refining liquid becomes disease ".The formation true essence of expectorant said in " refining " word.Short time is a burning with the bright thing of fire, is refining with the bright thing of fire for a long time.Illustrate in the body that a part of cloudy liquid is stifling for a long time and burn and be expectorant at last by fire.Expectorant is tangible body, is divided into multiple: cold-phlegm, heat-phlegm, dry phlegm, phoenix expectorant, all accumulate in the lung, and the lung master breathes, abundant expectoration in it all can influence and squeeze atmosphere in the heart, big in the heart QI-insufficiency, must influence and consume body surface and defend gas, because of two gas adsorb mutually, the lip then cold sensation in teeth of dying.It is impaired to defend gas, wind and cold invasion and attack and in going into heat-transformation become expectorant.Among the present invention, Fructus Trichosanthis, the Rhizoma Pinelliae are the medicine of expectorant.
(4) blood circulation promoting and blood stasis dispelling: invigorate blood circulation: say " damp viscous " in the middle medical book.The sticking blood that can make becomes silk fabric, and flowing slows down, and arrhythmia causes cardiovascular and cerebrovascular disease easily, for apoplexy hides some dangers for.Say " expelling wind and removing dampness is invigorated blood circulation earlier; blood rheumatism alive is gone out naturally " clinical verification in the middle medical book, treat in the hypertensive prescription and should not add the phoenix medicine, because of the many liters of property of its medicine loose, blood pressure is increased, and in prescription, add the medicine invigorate blood circulation, and then go ailment said due to cold or exposure in invisible and exempt from the dizzy of brains, dampness removing is turbid to remove the bitterly heavy of the whole body in the whole body.Among the present invention, Radix Salviae Miltiorrhizae and Cortex Moutan are blood circulation promoting medicine.Blood stasis dispelling: damp chance fire is then thick, and is thick then stagnant, stagnant then obstructed, not the general rule stasis of blood.Wet meet fire and impurity is given birth to, the blood dirt is attached to blood vessel, day by day thickens to become fragile, and blood vessel attenuates, blood by the time lateral pressure of blood vessel increased, the compressing blood vessel makes blood vessel become narrower and narrower easily, even breaks.Use rhizoma sparganic and Rhizoma Curcumae to come blood stasis dispelling among the present invention.
(5) reinforcing is supporing yang: reinforcing: what congenital and day after tomorrow was originally arranged says that kidney is the human body the congenital foundation, i.e. the gas of Kidney-Yin, Yuanyang in the kidney, the gas of Kidney-Yin from about two kidneys, the gas of Yuanyang is the root of human life from the gate of vitality.The human body the foundation of acquired constitution is taste, the strong person of taste, and the people is fat strong, the weakness of the spleen and stomach person, human body is weak thin.So cultivate congenital and the foundation of acquired constitution, be to improve the body and culature originally.The Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Poria, Radix Codonopsis, the Radix Astragali, Fructus Corni and Fructus Lycii are realized this function among the present invention.Supporing yang: " yang deficiency is then cold ", hyperpietic, particularly old people, the fear of cold of being afraid of cold mostly, and the disease of the cold pain of waist lower limb is arranged more.Being afraid of cold, it is cold to fear, the performance of yang deficiency, and yang deficiency mainly is divided into two kinds of deficiency of spleen-YANG and insufficiency of kidney-YANG: deficiency of spleen-YANG, " damp-stagnancy is then given birth to cold for a long time ": insufficiency of kidney-YANG, " decline of the fire from the gate of life." among the present invention, spleen reinforcing sun medicine is the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis and Fructus Evodiae; Kidney yang-tonifying medicinal: Cortex Cinnamomi, Fructus Psoraleae and Herba Cistanches.
The present invention is that the raw material that comprises the following weight ratio is made,
Radix Codonopsis 10-30, Radix Astragali 20-60, Radix Rehmanniae 20-60, Radix Scrophulariae 20-60, Radix Ophiopogonis 15-40, Rhizoma Anemarrhenae 15-30, Radix Paeoniae Alba 15-40, Radix Angelicae Sinensis 10-30, Rhizoma Dioscoreae 20-50, Radix Scutellariae 10-30, Cortex Phellodendri 10-30, Fructus Gardeniae 10-30, Radix Sophorae Flavescentis 10-30, Semen Cassiae 20-60, Haematitum 20-60, Natrii Sulfas 10-50, Radix Et Rhizoma Rhei 10-20, Radix Salviae Miltiorrhizae 15-50, Cortex Moutan 10-30, rhizoma sparganic 10-20, Rhizoma Curcumae 10-20, Rhizoma Atractylodis 10-40, Rhizoma Atractylodis Macrocephalae 20-40, Poria 20-50, Rhizoma Alismatis 15-40, Fructus Trichosanthis 15-40, Rhizoma Pinelliae 10-30, Fructus Psoraleae 15-40, Fructus Corni 15-60, Fructus Evodiae 10-20, Cortex Cinnamomi 5-20, Fructus Lycii 20-60 and Herba Cistanches 15-40.
Compound method of the present invention is as follows: the Impurity removal with the above-mentioned raw materials medicine, be decocted in water for oral dose, and potion on the one, 15 days is a course of treatment.The taboo of taking medicine: drinks, pungent and rich savoury, anemia of pregnant woman's taboo.
The present invention; Clinical use result shows that following advantage is arranged:
1, each component of Chinese herbal medicine of selecting for use of the present invention, utilize the comprehensive function treatment hypertension of the Chinese medicine of respectively distinguishing the flavor of, to human body nonhazardous effect, show that through animal acute toxicity test the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and mice is 80g crude drug/kg to dosis tolerata of the present invention, is 10 times of clinical application, safety of medicine is reliable, and patient can feel at ease to take.
2, the present invention can treat and effect a radical cure hypertension effectively, has improved patient's life quality and the time greatly, and very high healing rehabilitation efficacy is arranged.The present invention improves General Symptoms by adjusting the body yang blood and qi, reach antihypertensive effect, evident in efficacy, and other relevant disease that hypertension causes also there is better curative effect, can prevention of cerebral hemorrhage, related complications such as apoplexy, coronary heart disease, hyperlipidemia, arteriosclerosis, improved quality of life of patient.
For showing medicine of the present invention, as follows through clinical test results to hypertensive therapeutic effect:
(1) physical data
The inventor carries out clinical observation treatment to 210 routine patients in 1999 so far.Male's 156 examples wherein, women's 54 examples, 30 years old to 78 years old age, 68 of essential hypertensions, 142 of secondary hypertensions.
(2) Therapeutic Method
With being decocted in water for oral dose, respectively once, 15 days is a course of treatment sooner or later with medicine of the present invention, recovers the speed treatment according to the state of an illness and does not wait in 15 days to 2 months.
(3) efficacy assessment standard
The present invention is mainly used in treatment hypertension, so hypertension symptom improvement situation and every detection index are divided into following four second month in a season as curative effect judging standard:
Cure: symptom all disappears; Main physics and chemistry detects index and is normally.
Produce effects: symptomatology is eliminated or cardinal symptom is eliminated; It is normal substantially that physics and chemistry detects index.
Effectively: cardinal symptom disappears substantially; Main physics and chemistry detects index and makes moderate progress.
Invalid: main physics and chemistry detects index and the preceding no change of treatment.
(4) therapeutic effect
Clinical cure 192 examples, produce effects 11 examples, effective 4 examples, invalid 3 examples, all cases all have no adverse reaction.
(5) sum up:
Clinical time: 10 years, curative effect: 15 days were effectively, and the course of treatment: general patient 15-20 days, it is normal that blood pressure recovers, patient with severe symptoms: 1-1.5 month transference cure, and blood pressure recovered normal in 2 months, effective percentage 98.6%, cure rate 91.4%, invalid 1.4%.
In a word, good effect of the present invention, instant effect has no side effect, effective percentage 98.6%, cure rate 91.4%, invalid 1.4%.
Four, the specific embodiment
Below in conjunction with the specific embodiment the present invention is made further describing, so that superiority of the present invention is better embodied.
Embodiment 1, Radix Codonopsis 10, the Radix Astragali 60, the Radix Rehmanniae 20, Radix Scrophulariae 50, Radix Ophiopogonis 40, the Rhizoma Anemarrhenae 30, the Radix Paeoniae Alba 15, Radix Angelicae Sinensis 20, Rhizoma Dioscoreae 30, Radix Scutellariae 10, Cortex Phellodendri 15, Fructus Gardeniae 30, Radix Sophorae Flavescentis 10, Semen Cassiae 60, Haematitum 40, Natrii Sulfas 10, Radix Et Rhizoma Rhei 20, Radix Salviae Miltiorrhizae 50, Cortex Moutan 10, rhizoma sparganic 20, Rhizoma Curcumae 10, Rhizoma Atractylodis 30, the Rhizoma Atractylodis Macrocephalae 20, Poria 50, Rhizoma Alismatis 15, Fructus Trichosanthis 40, the Rhizoma Pinelliae 10, Fructus Psoraleae 40, Fructus Corni 15, Fructus Evodiae 10, Cortex Cinnamomi 5, Fructus Lycii 30 and Herba Cistanches 40.The medicinal boiled water of above-mentioned raw materials was soaked about 1 hour, and the back decocts, and moisture content surpasses crude drug 2-3 centimetre during decoction,, filters and pours out medicinal liquid and can take with slow fire boiling after 20 minutes in water boiling back, divides the morning, noon and afternoon clothes.
Embodiment 2, Radix Codonopsis 30, the Radix Astragali 30, the Radix Rehmanniae 50, Radix Scrophulariae 60, Radix Ophiopogonis 30, the Rhizoma Anemarrhenae 20, the Radix Paeoniae Alba 30, Radix Angelicae Sinensis 30, Rhizoma Dioscoreae 40, Radix Scutellariae 20, Cortex Phellodendri 25, Fructus Gardeniae 25, Radix Sophorae Flavescentis 20, Semen Cassiae 40, Haematitum 60, Natrii Sulfas 40, Radix Et Rhizoma Rhei 15, Radix Salviae Miltiorrhizae 30, Cortex Moutan 20, rhizoma sparganic 10, Rhizoma Curcumae 17, Rhizoma Atractylodis 10, the Rhizoma Atractylodis Macrocephalae 40, Poria 30, Rhizoma Alismatis 30, Fructus Trichosanthis 20, the Rhizoma Pinelliae 30, Fructus Psoraleae 20, Fructus Corni 30, Fructus Evodiae 20, Cortex Cinnamomi 15, Fructus Lycii 50 and Herba Cistanches 20.Boil medicine and take with embodiment 1.
Embodiment 3, Radix Codonopsis 20, the Radix Astragali 50, the Radix Rehmanniae 40, Radix Scrophulariae 40, Radix Ophiopogonis 15, the Rhizoma Anemarrhenae 15, the Radix Paeoniae Alba 20, Radix Angelicae Sinensis 10, Rhizoma Dioscoreae 20, Radix Scutellariae 15, Cortex Phellodendri 10, Fructus Gardeniae 20, Radix Sophorae Flavescentis 30, Semen Cassiae 50, Haematitum 50, Natrii Sulfas 30, Radix Et Rhizoma Rhei 10, Radix Salviae Miltiorrhizae 40, Cortex Moutan 15, rhizoma sparganic 15, Rhizoma Curcumae 12, Rhizoma Atractylodis 20, the Rhizoma Atractylodis Macrocephalae 30, Poria 20, Rhizoma Alismatis 20, Fructus Trichosanthis 30, the Rhizoma Pinelliae 20, Fructus Psoraleae 15, Fructus Corni 20, Fructus Evodiae 15, Cortex Cinnamomi 10, Fructus Lycii 40 and Herba Cistanches 30.Boil medicine and take with embodiment 1.
Embodiment 4, Radix Codonopsis 15, the Radix Astragali 40, the Radix Rehmanniae 30, Radix Scrophulariae 20, Radix Ophiopogonis 35, the Rhizoma Anemarrhenae 25, the Radix Paeoniae Alba 25, Radix Angelicae Sinensis 15, Rhizoma Dioscoreae 50, Radix Scutellariae 25, Cortex Phellodendri 30, Fructus Gardeniae 15, Radix Sophorae Flavescentis 25, Semen Cassiae 30, Haematitum 20, Natrii Sulfas 50, Radix Et Rhizoma Rhei 18, Radix Salviae Miltiorrhizae 20, Cortex Moutan 25, rhizoma sparganic 12, Rhizoma Curcumae 13, Rhizoma Atractylodis 40, the Rhizoma Atractylodis Macrocephalae 25, Poria 40, Rhizoma Alismatis 40, Fructus Trichosanthis 15, the Rhizoma Pinelliae 25, Fructus Psoraleae 30, Fructus Corni 45, Fructus Evodiae 13, Cortex Cinnamomi 20, Fructus Lycii 60 and Herba Cistanches 15.Boil medicine and take with embodiment 1.
Embodiment 5, Radix Codonopsis 10, the Radix Astragali 30, the Radix Rehmanniae 40, Radix Scrophulariae 20, Radix Ophiopogonis 25, the Rhizoma Anemarrhenae 15, the Radix Paeoniae Alba 20, Radix Angelicae Sinensis 30, Rhizoma Dioscoreae 40, Radix Scutellariae 20, Cortex Phellodendri 10, Fructus Gardeniae 20, Radix Sophorae Flavescentis 30, Semen Cassiae 40, Haematitum 20, Natrii Sulfas 30, Radix Et Rhizoma Rhei 20, Radix Salviae Miltiorrhizae 45, Cortex Moutan 25, rhizoma sparganic 10, Rhizoma Curcumae 15, Rhizoma Atractylodis 35, the Rhizoma Atractylodis Macrocephalae 25, Poria 50, Rhizoma Alismatis 30, Fructus Trichosanthis 15, the Rhizoma Pinelliae 20, Fructus Psoraleae 15, Fructus Corni 50, Fructus Evodiae 20, Cortex Cinnamomi 5, Fructus Lycii 40 and Herba Cistanches 15.Boil medicine and take with embodiment 1.
Embodiment 6, Radix Codonopsis 25, the Radix Astragali 20, the Radix Rehmanniae 60, Radix Scrophulariae 30, Radix Ophiopogonis 20, the Rhizoma Anemarrhenae 18, the Radix Paeoniae Alba 40, Radix Angelicae Sinensis 25, Rhizoma Dioscoreae 35, Radix Scutellariae 30, Cortex Phellodendri 20, Fructus Gardeniae 10, Radix Sophorae Flavescentis 15, Semen Cassiae 20, Haematitum 30, Natrii Sulfas 20, Radix Et Rhizoma Rhei 13, Radix Salviae Miltiorrhizae 15, Cortex Moutan 30, rhizoma sparganic 17, Rhizoma Curcumae 15, Rhizoma Atractylodis 25, the Rhizoma Atractylodis Macrocephalae 35, Poria 45, Rhizoma Alismatis 25, Fructus Trichosanthis 25, the Rhizoma Pinelliae 15, Fructus Psoraleae 35, Fructus Corni 60, Fructus Evodiae 18, Cortex Cinnamomi 18, Fructus Lycii 20 and Herba Cistanches 35.Boil medicine and take with embodiment 1.
Embodiment 7, Radix Codonopsis 12, the Radix Astragali 25, the Radix Rehmanniae 45, Radix Scrophulariae 35, Radix Ophiopogonis 25, the Rhizoma Anemarrhenae 23, the Radix Paeoniae Alba 35, Radix Angelicae Sinensis 22, Rhizoma Dioscoreae 25, Radix Scutellariae 23, Cortex Phellodendri 13, Fructus Gardeniae 27, Radix Sophorae Flavescentis 13, Semen Cassiae 45, Haematitum 55, Natrii Sulfas 35, Radix Et Rhizoma Rhei 16, Radix Salviae Miltiorrhizae 25, Cortex Moutan 23, rhizoma sparganic 18, Rhizoma Curcumae 16, Rhizoma Atractylodis 15, the Rhizoma Atractylodis Macrocephalae 27, Poria 35, Rhizoma Alismatis 35, Fructus Trichosanthis 35, the Rhizoma Pinelliae 18, Fructus Psoraleae 25, Fructus Corni 40, Fructus Evodiae 16, Cortex Cinnamomi 13, Fructus Lycii 45 and Herba Cistanches 25.Boil medicine and take with embodiment 1.
Claims (8)
1., the hypertensive Chinese medicine of a kind of treatment is characterized in that: it is that the raw material that comprises the following weight ratio is made Radix Codonopsis 10-30, Radix Astragali 20-60, Radix Rehmanniae 20-60, Radix Scrophulariae 20-60, Radix Ophiopogonis 15-40, Rhizoma Anemarrhenae 15-30, Radix Paeoniae Alba 15-40, Radix Angelicae Sinensis 10-30, Rhizoma Dioscoreae 20-50, Radix Scutellariae 10-30, Cortex Phellodendri 10-30, Fructus Gardeniae 10-30, Radix Sophorae Flavescentis 10-30, Semen Cassiae 20-60, Haematitum 20-60, Natrii Sulfas 10-50, Radix Et Rhizoma Rhei 10-20, Radix Salviae Miltiorrhizae 15-50, Cortex Moutan 10-30, rhizoma sparganic 10-20, Rhizoma Curcumae 10-20, Rhizoma Atractylodis 10-40, Rhizoma Atractylodis Macrocephalae 20-40, Poria 20-50, Rhizoma Alismatis 15-40, Fructus Trichosanthis 15-40, Rhizoma Pinelliae 10-30, Fructus Psoraleae 15-40, Fructus Corni 15-60, Fructus Evodiae 10-20, Cortex Cinnamomi 5-20, Fructus Lycii 20-60 and Herba Cistanches 15-40.
, the hypertensive Chinese medicine of treatment according to claim 1, it is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 10, the Radix Astragali 60, the Radix Rehmanniae 20, Radix Scrophulariae 50, Radix Ophiopogonis 40, the Rhizoma Anemarrhenae 30, the Radix Paeoniae Alba 15, Radix Angelicae Sinensis 20, Rhizoma Dioscoreae 30, Radix Scutellariae 10, Cortex Phellodendri 15, Fructus Gardeniae 30, Radix Sophorae Flavescentis 10, Semen Cassiae 60, Haematitum 40, Natrii Sulfas 10, Radix Et Rhizoma Rhei 20, Radix Salviae Miltiorrhizae 50, Cortex Moutan 10, rhizoma sparganic 20, Rhizoma Curcumae 10, Rhizoma Atractylodis 30, the Rhizoma Atractylodis Macrocephalae 20, Poria 50, Rhizoma Alismatis 15, Fructus Trichosanthis 40, the Rhizoma Pinelliae 10, Fructus Psoraleae 40, Fructus Corni 15, Fructus Evodiae 10, Cortex Cinnamomi 5, Fructus Lycii 30 and Herba Cistanches 40.
, the hypertensive Chinese medicine of treatment according to claim 1, it is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 30, the Radix Astragali 30, the Radix Rehmanniae 50, Radix Scrophulariae 60, Radix Ophiopogonis 30, the Rhizoma Anemarrhenae 20, the Radix Paeoniae Alba 30, Radix Angelicae Sinensis 30, Rhizoma Dioscoreae 40, Radix Scutellariae 20, Cortex Phellodendri 25, Fructus Gardeniae 25, Radix Sophorae Flavescentis 20, Semen Cassiae 40, Haematitum 60, Natrii Sulfas 40, Radix Et Rhizoma Rhei 15, Radix Salviae Miltiorrhizae 30, Cortex Moutan 20, rhizoma sparganic 10, Rhizoma Curcumae 17, Rhizoma Atractylodis 10, the Rhizoma Atractylodis Macrocephalae 40, Poria 30, Rhizoma Alismatis 30, Fructus Trichosanthis 20, the Rhizoma Pinelliae 30, Fructus Psoraleae 20, Fructus Corni 30, Fructus Evodiae 20, Cortex Cinnamomi 15, Fructus Lycii 50 and Herba Cistanches 20.
4, the hypertensive Chinese medicine of treatment according to claim 1 is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 20, the Radix Astragali 50, the Radix Rehmanniae 40, Radix Scrophulariae 40, Radix Ophiopogonis 15, the Rhizoma Anemarrhenae 15, the Radix Paeoniae Alba 20, Radix Angelicae Sinensis 10, Rhizoma Dioscoreae 20, Radix Scutellariae 15, Cortex Phellodendri 10, Fructus Gardeniae 20, Radix Sophorae Flavescentis 30, Semen Cassiae 50, Haematitum 50, Natrii Sulfas 30, Radix Et Rhizoma Rhei 10, Radix Salviae Miltiorrhizae 40, Cortex Moutan 15, rhizoma sparganic 15, Rhizoma Curcumae 12, Rhizoma Atractylodis 20, the Rhizoma Atractylodis Macrocephalae 30, Poria 20, Rhizoma Alismatis 20, Fructus Trichosanthis 30, the Rhizoma Pinelliae 20, Fructus Psoraleae 15, Fructus Corni 20, Fructus Evodiae 15, Cortex Cinnamomi 10, Fructus Lycii 40 and Herba Cistanches 30.
, the hypertensive Chinese medicine of treatment according to claim 1, it is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 15, the Radix Astragali 40, the Radix Rehmanniae 30, Radix Scrophulariae 20, Radix Ophiopogonis 35, the Rhizoma Anemarrhenae 25, the Radix Paeoniae Alba 25, Radix Angelicae Sinensis 15, Rhizoma Dioscoreae 50, Radix Scutellariae 25, Cortex Phellodendri 30, Fructus Gardeniae 15, Radix Sophorae Flavescentis 25, Semen Cassiae 30, Haematitum 20, Natrii Sulfas 50, Radix Et Rhizoma Rhei 18, Radix Salviae Miltiorrhizae 20, Cortex Moutan 25, rhizoma sparganic 12, Rhizoma Curcumae 13, Rhizoma Atractylodis 40, the Rhizoma Atractylodis Macrocephalae 25, Poria 40, Rhizoma Alismatis 40, Fructus Trichosanthis 15, the Rhizoma Pinelliae 25, Fructus Psoraleae 30, Fructus Corni 45, Fructus Evodiae 13, Cortex Cinnamomi 20, Fructus Lycii 60 and Herba Cistanches 15.
, the hypertensive Chinese medicine of treatment according to claim 1, it is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 10, the Radix Astragali 30, the Radix Rehmanniae 40, Radix Scrophulariae 20, Radix Ophiopogonis 25, the Rhizoma Anemarrhenae 15, the Radix Paeoniae Alba 20, Radix Angelicae Sinensis 30, Rhizoma Dioscoreae 40, Radix Scutellariae 20, Cortex Phellodendri 10, Fructus Gardeniae 20, Radix Sophorae Flavescentis 30, Semen Cassiae 40, Haematitum 20, Natrii Sulfas 30, Radix Et Rhizoma Rhei 20, Radix Salviae Miltiorrhizae 45, Cortex Moutan 25, rhizoma sparganic 10, Rhizoma Curcumae 15, Rhizoma Atractylodis 35, the Rhizoma Atractylodis Macrocephalae 25, Poria 50, Rhizoma Alismatis 30, Fructus Trichosanthis 15, the Rhizoma Pinelliae 20, Fructus Psoraleae 15, Fructus Corni 50, Fructus Evodiae 20, Cortex Cinnamomi 5, Fructus Lycii 40 and Herba Cistanches 15.
7, the hypertensive Chinese medicine of treatment according to claim 1 is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 25, the Radix Astragali 20, the Radix Rehmanniae 60, Radix Scrophulariae 30, Radix Ophiopogonis 20, the Rhizoma Anemarrhenae 18, the Radix Paeoniae Alba 40, Radix Angelicae Sinensis 25, Rhizoma Dioscoreae 35, Radix Scutellariae 30, Cortex Phellodendri 20, Fructus Gardeniae 10, Radix Sophorae Flavescentis 15, Semen Cassiae 20, Haematitum 30, Natrii Sulfas 20, Radix Et Rhizoma Rhei 13, Radix Salviae Miltiorrhizae 15, Cortex Moutan 30, rhizoma sparganic 17, Rhizoma Curcumae 15, Rhizoma Atractylodis 25, the Rhizoma Atractylodis Macrocephalae 35, Poria 45, Rhizoma Alismatis 25, Fructus Trichosanthis 25, the Rhizoma Pinelliae 15, Fructus Psoraleae 35, Fructus Corni 60, Fructus Evodiae 18, Cortex Cinnamomi 18, Fructus Lycii 20 and Herba Cistanches 35.
, the hypertensive Chinese medicine of treatment according to claim 1, it is characterized in that: it is that the raw material that comprises the following weight ratio is made, Radix Codonopsis 12, the Radix Astragali 25, the Radix Rehmanniae 45, Radix Scrophulariae 35, Radix Ophiopogonis 25, the Rhizoma Anemarrhenae 23, the Radix Paeoniae Alba 35, Radix Angelicae Sinensis 22, Rhizoma Dioscoreae 25, Radix Scutellariae 23, Cortex Phellodendri 13, Fructus Gardeniae 27, Radix Sophorae Flavescentis 13, Semen Cassiae 45, Haematitum 55, Natrii Sulfas 35, Radix Et Rhizoma Rhei 16, Radix Salviae Miltiorrhizae 25, Cortex Moutan 23, rhizoma sparganic 18, Rhizoma Curcumae 16, Rhizoma Atractylodis 15, the Rhizoma Atractylodis Macrocephalae 27, Poria 35, Rhizoma Alismatis 35, Fructus Trichosanthis 35, the Rhizoma Pinelliae 18, Fructus Psoraleae 25, Fructus Corni 40, Fructus Evodiae 16, Cortex Cinnamomi 13, Fructus Lycii 45 and Herba Cistanches 25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910075332A CN101670070A (en) | 2009-09-09 | 2009-09-09 | Traditional Chinese medicine composition for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910075332A CN101670070A (en) | 2009-09-09 | 2009-09-09 | Traditional Chinese medicine composition for treating hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101670070A true CN101670070A (en) | 2010-03-17 |
Family
ID=42017626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910075332A Pending CN101670070A (en) | 2009-09-09 | 2009-09-09 | Traditional Chinese medicine composition for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101670070A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810801A (en) * | 2010-05-30 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating hypertension and preparation method thereof |
| CN102697933A (en) * | 2012-06-19 | 2012-10-03 | 黄芸 | Lotus leaf traditional Chinese medicine oral liquid for relieving hypertension and preparation method for oral liquid |
| CN102698054A (en) * | 2012-01-17 | 2012-10-03 | 李付德 | Traditional Chinese medicine composition for treating yang-deficiency monophasic-type high-high-pressure hypertension |
| CN102908599A (en) * | 2012-06-19 | 2013-02-06 | 谢文龙 | Medicine capable of reducing blood sugar, blood fat and blood pressure |
| CN103041200A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating cerebral hemorrhage |
| CN103550727A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine composition for treating hypertension |
| CN103656007A (en) * | 2013-11-29 | 2014-03-26 | 刘艺 | Traditional Chinese medicine formula for treating coronary heart disease |
| CN103768528A (en) * | 2014-01-18 | 2014-05-07 | 史克勇 | Traditional chinese medicine composition |
| CN104257959A (en) * | 2014-09-23 | 2015-01-07 | 苏州市天灵中药饮片有限公司 | Antihypertensive traditional Chinese medicine extract and preparation method thereof |
| CN104721530A (en) * | 2015-02-27 | 2015-06-24 | 周舜宁 | Antihypertensive traditional Chinese medicine composition |
| CN107456546A (en) * | 2017-08-15 | 2017-12-12 | 晁伟岩 | It is capable of the preparation method of the oat oral liquid of three high drop |
-
2009
- 2009-09-09 CN CN200910075332A patent/CN101670070A/en active Pending
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810801A (en) * | 2010-05-30 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating hypertension and preparation method thereof |
| CN102698054A (en) * | 2012-01-17 | 2012-10-03 | 李付德 | Traditional Chinese medicine composition for treating yang-deficiency monophasic-type high-high-pressure hypertension |
| CN102697933A (en) * | 2012-06-19 | 2012-10-03 | 黄芸 | Lotus leaf traditional Chinese medicine oral liquid for relieving hypertension and preparation method for oral liquid |
| CN102908599A (en) * | 2012-06-19 | 2013-02-06 | 谢文龙 | Medicine capable of reducing blood sugar, blood fat and blood pressure |
| CN103041200B (en) * | 2012-12-21 | 2015-01-07 | 姜艳芹 | Traditional Chinese medicine composition for treating cerebral hemorrhage |
| CN103041200A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating cerebral hemorrhage |
| CN103550727A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine composition for treating hypertension |
| CN103550727B (en) * | 2013-10-26 | 2015-11-18 | 岳华 | One treats hypertensive Chinese medicine composition |
| CN103656007A (en) * | 2013-11-29 | 2014-03-26 | 刘艺 | Traditional Chinese medicine formula for treating coronary heart disease |
| CN103768528A (en) * | 2014-01-18 | 2014-05-07 | 史克勇 | Traditional chinese medicine composition |
| CN104257959A (en) * | 2014-09-23 | 2015-01-07 | 苏州市天灵中药饮片有限公司 | Antihypertensive traditional Chinese medicine extract and preparation method thereof |
| CN104257959B (en) * | 2014-09-23 | 2018-06-22 | 苏州市天灵中药饮片有限公司 | A kind of Chinese medical extract of blood pressure lowering and preparation method thereof |
| CN104721530A (en) * | 2015-02-27 | 2015-06-24 | 周舜宁 | Antihypertensive traditional Chinese medicine composition |
| CN107456546A (en) * | 2017-08-15 | 2017-12-12 | 晁伟岩 | It is capable of the preparation method of the oat oral liquid of three high drop |
| CN107456546B (en) * | 2017-08-15 | 2018-11-13 | 潘柳臻 | It is capable of the preparation method of the oat oral solution of lower hyperlipidemia, hypertension, hyperglycemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101670070A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN100506266C (en) | Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN102335380A (en) | Drug for treating cardiovascular and cerebrovascular diseases, and preparation method thereof | |
| CN101675982A (en) | Traditional Chinese medicine composition for warming heart yang and reducing phlegm and absorbing clots | |
| CN104667047A (en) | Traditional Chinese medicine liquor for treating diabetic feet | |
| CN104324355A (en) | Traditional Chinese medicine composition for treating peripheral neuropathy caused by diabetes | |
| CN103028090A (en) | Traditional Chinese medicine composition for treating Qi deficiency | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN104435799A (en) | Traditional Chinese medicine granules for treating kidney failure and inspection method thereof | |
| CN105250890A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN105395911A (en) | Traditional Chinese medicine for curing cerebral thrombosis | |
| CN101401891B (en) | Traditional Chinese medicine decoction for treating aplastic anemia | |
| CN101342349A (en) | Traditional Chinese medicine for treating hyperpiesis and myocardium disease | |
| CN103041228A (en) | Traditional Chinese medicine composite for treating myasthenia gravis | |
| CN100387283C (en) | Chinese traditional medicine for treating diabetes retinopathy | |
| CN103055072B (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN101085273A (en) | Traditional Chinese medicine composition for curing hypomenorrhea | |
| CN104548012A (en) | Traditional Chinese medicine composition for treating amyloid cardiomyopathy | |
| CN102397403A (en) | Medicine for treating kidney dysfunction | |
| CN103006998B (en) | Medicine for treating acute glomerulonephritis (AGN) hypertensive crisis | |
| CN103656565A (en) | Drug for treating Qi and Yin deficiency type myocardial infarction | |
| CN103417857B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN101829306A (en) | Traditional Chinese medicine composition for treating hemiplegia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100317 |